Dynavax's Chronic Kidney Disease Study Confirms HEPLISAV's Enhanced ... - MarketWatch (press release) PDF Print
MarketWatch (press release)In 2006, there were approximately 750000 end-stage renal disease (ESRD) patients in the United States and the five major European markets;

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.